RBR suspension covers proposed raise and convertible notes

RBR Suspended Ahead of Financing Announcement

RBR Group Limited (ASX:RBR) has been suspended from quotation at its own request as it prepares a market announcement covering a proposed capital raising and the extension of its convertible notes. The suspension took effect after the existing trading halt on Thursday, 12 November, under ASX Listing Rule 17.2.

The company told ASX it was still finalising the capital-raising documentation and agreements with its noteholders, leaving it unable to release the announcement before the trading halt expired. The proposed financing arrives after RBR’s April share placement, which raised $365,000 and was accompanied by plans to restructure existing debt facilities.

Capital Raising Terms Remain Undisclosed

RBR has not disclosed the amount to be raised, issue price, proposed structure, use of funds or expected dilution. Nor has it released the revised maturity, conversion or other terms that may apply to the convertible notes. Those details will determine whether the announcement represents a straightforward funding measure or a more substantial reshaping of the company’s capital structure.

The timing is material because RBR’s recent operating update described only A$32,000 in cash at quarter end and approximately A$1.25 million of overdue convertible notes, while also reporting a new Mozambique LNG contract. The current filing does not state whether the proposed capital raising or note extension has been committed, nor whether any conditions remain outstanding.

Trading Deadline Set for 13 November

Unless ASX determines otherwise, the securities will remain suspended until the earlier of the release of RBR’s financing announcement or the end of the suspension period requested by the company. RBR said that period runs until before trading begins on Friday, 13 November 2026.

The next announcement should therefore provide the first meaningful test of how RBR intends to bridge its funding needs while pursuing its Mozambique opportunities. Until the terms are published, shareholders have no disclosed basis for measuring the potential dilution, the relief provided by any note extension, or the funding runway created by the transaction.